Astellas shells out $35M upfront to Cullgen in protein degrader development deal
Astellas is expanding its mark in the growing protein degradation space with a potential $1.9 billion deal with San Diego and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
